Steven Cohen Neuro Pace Inc Call Options Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NPCE
# of Institutions
65Shares Held
21.7MCall Options Held
23.2KPut Options Held
800-
Kck Ltd. Tortola, D85.27MShares$75 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$48.5 Million1.03% of portfolio
-
Morgan Stanley New York, NY2.49MShares$35.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$34.6 Million1.9% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.48MShares$21.1 Million7.02% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $354M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...